Skip to content

Tresiba

Published: July 26, 2026Updated: August 25, 2026

Tresiba is a brand-name long-acting insulin used to manage blood sugar in adults and children with diabetes. It provides steady glucose control over an extended period, helping to maintain stable blood sugar levels throughout the day and night. This medication is typically prescribed as part of a comprehensive diabetes management plan that may include diet, exercise, and other medications.

Quick summary

Tresiba is a long-acting insulin that helps control blood sugar levels in people with diabetes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

RxNorm
1670012
Generic
Tresiba
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Tresiba is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children. It is used to improve glycemic control alongside proper diet and exercise. This basal insulin can be used alone or in combination with other diabetes medications, including rapid-acting insulins or oral antidiabetic drugs.

Tresiba contains insulin degludec, a basal insulin analog that works by binding to insulin receptors on cells throughout the body. It promotes the uptake of glucose from the blood into cells for energy and reduces the liver's production of glucose. Its prolonged duration of action provides a steady, flat insulin profile that helps maintain stable blood sugar levels over approximately 42 hours.

Tresiba is administered as a subcutaneous injection once daily and can be given at any time of day, though a consistent dosing schedule is recommended. Like all insulins, it carries the risk of hypoglycemia and should not be used during episodes of low blood sugar. Patients should rotate injection sites and monitor blood glucose regularly. It is available in both a flexible-dose pen and a traditional vial/syringe formulation.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy